Qube Research & Technologies Ltd - ATARA BIOTHERAPEUTICS INC ownership

ATARA BIOTHERAPEUTICS INC's ticker is ATRA and the CUSIP is 046513107. A total of 125 filers reported holding ATARA BIOTHERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.2%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of ATARA BIOTHERAPEUTICS INC
ValueSharesWeighting
Q2 2023$56,202
-69.4%
34,908
-37.7%
0.00%
-100.0%
Q4 2022$183,670
-16.5%
55,997
+136.6%
0.00%
-50.0%
Q1 2022$220,000
-27.9%
23,670
+20.7%
0.00%
-33.3%
Q2 2021$305,000
-74.0%
19,606
-76.0%
0.00%
-84.2%
Q1 2021$1,175,000
+32.3%
81,795
+80.9%
0.02%
+46.2%
Q4 2020$888,00045,2240.01%
Other shareholders
ATARA BIOTHERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Redmile Group, LLC 2,275,765$43,308,0004.43%
RTW INVESTMENTS, LP 473,126$9,004,0003.27%
Baupost Group 5,359,632$101,994,0001.47%
12 West Capital Management LP 398,700$7,587,0001.05%
BRIDGER MANAGEMENT, LLC 739,444$14,072,0000.97%
Cormorant Asset Management, LP 150,000$2,855,0000.43%
ArrowMark Colorado Holdings LLC 850,040$16,176,0000.36%
Virtus ETF Advisers LLC 11,431$218,0000.30%
Visium Asset Management, LP 606,221$11,536,0000.20%
EAGLE ASSET MANAGEMENT INC 1,025,988$19,524,0000.14%
View complete list of ATARA BIOTHERAPEUTICS INC shareholders